logo
搜索
菜单

的搜索结果

当前367/740页
排序: 最近更新
14.14: Criteria for Causality: Bradford Hill Criteria – II 01:28 min
14.14: Criteria for Causality: Bradford Hill Criteria – II
14.7: Response Surface Methodology 01:16 min
14.7: Response Surface Methodology
14.6: Study Designs in Epidemiology 01:20 min
14.6: Study Designs in Epidemiology
14.5: Receiver Operating Characteristic Plot 01:15 min
14.5: Receiver Operating Characteristic Plot
14.4: Sensitivity, Specificity, and Predicted Value 01:13 min
14.4: Sensitivity, Specificity, and Predicted Value
14.3: Prevalence and Incidence 01:08 min
14.3: Prevalence and Incidence
14.2: Introduction to Epidemiology 01:26 min
14.2: Introduction to Epidemiology
14.1: Overview of Biostatistics in Health Sciences 01:19 min
14.1: Overview of Biostatistics in Health Sciences
13.19: Friedman Two-way Analysis of Variance by Ranks 01:21 min
13.19: Friedman Two-way Analysis of Variance by Ranks
13.18: Fisher's Exact Test 01:08 min
13.18: Fisher's Exact Test
13.17: Behrens–Fisher Test 00:57 min
13.17: Behrens–Fisher Test
3.2: Titration of a Strong Acid with a Strong Base 01:23 min
3.2: Titration of a Strong Acid with a Strong Base
3.1: Acid–Base Titration: Overview 01:26 min
3.1: Acid–Base Titration: Overview
1.22: What is ANOVA? 01:13 min
1.22: What is ANOVA?
1.8: Introduction to z Scores 01:05 min
1.8: Introduction to z Scores
1.18: Steel Manufacturing 01:26 min
1.18: Steel Manufacturing
25.16: Hypoglycemia and Glucagon 01:15 min
25.16: Hypoglycemia and Glucagon
25.15: Dipeptidyl Peptidase 4 Inhibitors 01:23 min
25.15: Dipeptidyl Peptidase 4 Inhibitors
25.14: Glucagon-like Receptor Agonists 01:24 min
25.14: Glucagon-like Receptor Agonists
25.13: Oral Hypoglycemic Agents: α-Glucosidase Inhibitors 01:19 min
25.13: Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
返回顶部